Volume 11, Issue 5 pp. 331-336

Microarray Analysis of Leukocytapheresis-induced Changes in Gene Expression Patterns of Peripheral Blood Mononuclear Cells in Patients With Ulcerative Colitis

Yuhki Yagi

Yuhki Yagi

Department of Medicine,

Search for more papers by this author
Akira Andoh

Corresponding Author

Akira Andoh

Department of Medicine,

Dr Akira Andoh, Department of Medicine, Shiga University of Medical Science, Seta-Tukinowa, Otsu 520-2192, Japan. Email: [email protected]Search for more papers by this author
Atsuhiro Ogawa

Atsuhiro Ogawa

Department of Medicine,

Search for more papers by this author
Shigeki Bamba

Shigeki Bamba

Department of Medicine,

Search for more papers by this author
Tomoyuki Tsujikawa

Tomoyuki Tsujikawa

Department of Medicine,

Search for more papers by this author
Masaya Sasaki

Masaya Sasaki

Division of Nutrition, Shiga University of Medical Science, Otsu, and

Search for more papers by this author
Keiichi Mitsuyama

Keiichi Mitsuyama

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Search for more papers by this author
Yoshihide Fujiyama

Yoshihide Fujiyama

Department of Medicine,

Search for more papers by this author
First published: 05 September 2007
Citations: 6

Presented in part at the 26th Annual Meeting of the Japanese Society for Apheresis held 28–29 July 2006 in Otsu, Japan.

Abstract

Abstract: To elucidate the molecular mechanisms involved in the therapeutic effects of leukocytapheresis (LCAP), we performed microarray analysis for gene expression patterns in peripheral blood mononuclear cells (PBMCs) before and after LCAP therapy in patients with ulcerative colitis (UC). Four patients with UC were enrolled. PBMCs were isolated from peripheral venous blood obtained within 5 min before and after the first session of LCAP therapy. Cells were stimulated with IL-1β for 12 h, and gene expression patterns were analyzed by an IntelliGene HS Human Expression Chip. The LCAP session reduced various genes, such as proinflammatory cytokines (IL-1α, IL-1β, IL-6, IL-8, TNF-α, and IFN-γ), cytokine receptors (IL-1R and IL-2Rα), chemokines, chemokine receptors, and intracellular signal transduction molecules. Genes which had increased after the LCAP session included those regulating anti-inflammatory cytokines and proteins (TGF-β1 and IL-R antagonist), receptors for anti-inflammatory cytokines (IL-10R and IL-4R), growth factor receptors (IGF-R1, R2) and antioxidant proteins. Total changes in gene expression patterns after LCAP session were a combination of a decrease in pro-inflammatory genes and an enhancement of anti-inflammatory genes. These changes may explain some parts of the mechanisms by which LCAP improves clinical symptoms of UC patients.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.